Decreased antigen presentation by dendritic cells in patients with breast cancer.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Clinical Cancer Research

• Publication date

  1997-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 9815709
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dendritic cells in antitumor immune responses. I. Defective antigen presentation in tumor-bearing hosts.

  1996cited by this paper
• Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines

  1996cited by this paper
• Vaccination of patients with B–cell lymphoma using autologous antigen–pulsed dendritic cells

  1996cited by this paper
• Dendritic cells in antitumor immune responses. II. Dendritic cells grown from bone marrow precursors, but not mature DC from tumor-bearing mice, are effective antigen carriers in the therapy of established tumors.

  1996cited by this paper
• Generation of antigen‐presenting cells for soluble protein antigens ex vivo from peripheral blood CD34+ hematopoietic progenitor cells in cancer patients

  1996cited by this paper
• Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells

  1996cited by this paper
• Molecular and functional characteristics of dendritic cells generated from highly purified CD14+ peripheral blood monocytes.

  1996cited by this paper
• Activated macrophages induce structural abnormalities of the T cell receptor-CD3 complex

  1995cited by this paper
• Generation of immunostimulatory dendritic cells from human CD34+ hematopoietic progenitor cells of the bone marrow and peripheral blood.

  1995cited by this paper
• Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity

  1995cited by this paper
• Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

  1994cited by this paper
• Proliferating dendritic cell progenitors in human blood

  1994cited by this paper
• Influenza virus-infected dendritic cells stimulate strong proliferative and cytolytic responses from human CD8+ T cells.

  1994cited by this paper
• Epidermal cell presentation of tumor-associated antigens for induction of tolerance.

  1994cited by this paper
• Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens.

  1994cited by this paper
• Human blood contains two subsets of dendritic cells, one immunologically mature and the other immature.

  1994cited by this paper
• Characterization of antigen-presenting cells that present exogenous antigens in association with class I MHC molecules.

  1993cited by this paper
• T cell recognition of human tumors: implications for molecular immunotherapy of cancer.

  1993cited by this paper
• Variations in the distribution, frequency, and phenotype of Langerhans cells during the evolution of malignant melanoma of the skin.

  1993cited by this paper
• Depressed monocyte polarization and clustering of dendritic cells in patients with head and neck cancer: In vitro restoration of this immunosuppression by thymic hormones

  1993cited by this paper
• Structural compartmentalization of MHC class II signaling function.

  1993cited by this paper
• Isolation and characterization of human peripheral blood dendritic cells.

  1993cited by this paper
• Costimulation of T-cell growth.

  1992cited by this paper
• Tumor-bearing mice exhibit a progressive increase in tumor antigen-presenting cell function and a reciprocal decrease in tumor antigen-responsive CD4+ T cell activity.

  1992cited by this paper
• Human tumor infiltrating lymphocytes. Analysis of lymphokine mRNA expression and relevance to cancer immunotherapy.

  1989cited by this paper
• Activation of T lymphocytes by immobilized monoclonal antibodies to CD3. Regulatory influences of monoclonal antibodies to additional T cell surface determinants.

  1988cited by this paper
• Characterization of cells from invaded lymph nodes in patients with solid tumors. Lymphokine requirement for tumor-specific lymphoproliferative response

  1987cited by this paper

• The Trojan Horse Within: Mechanisms of Immune Evasion in Breast Cancer

  2025cites this paper
• Interrogating the roles of lymph node metastasis in systemic immune surveillance

  2024cites this paper
• Tumor-associated NK cells drive MDSC-mediated tumor immune tolerance through the IL-6/STAT3 axis

  2024cites this paper
• Engineering an active immunotherapy for personalized cancer treatment and prevention of recurrence

  2023cites this paper
• Exosome regulation of immune response mechanism: Pros and cons in immunotherapy

  2023influential citation
• The Changing Landscape of Immunotherapy for Advanced Renal Cancer.

  2023cites this paper
• Ready for Prime Time? Dendritic Cells in High-Grade Gliomas

  2023cites this paper
• Antigen cross-presentation by dendritic cells: A critical axis in cancer immunotherapy.

  2023cites this paper
• The Unfolded Protein Response at the Tumor-Immune Interface

  2022cites this paper
• Metastasis Role of myeloid cells in the tumor microenvironment

  2022cites this paper
• Breast Cancer Stem-Like Cells in Drug Resistance: A Review of Mechanisms and Novel Therapeutic Strategies to Overcome Drug Resistance

  2022cites this paper
• The Peripheral Immune Landscape of Breast Cancer: Clinical Findings and In Vitro Models for Biomarker Discovery

  2021influential citation
• Systemic immunity upon local oncolytic virotherapy armed with immunostimulatory genes may be supported by tumor-derived exosomes

  2021cites this paper
• The roles of tumor-derived exosomes in altered differentiation, maturation and function of dendritic cells

  2021cites this paper
• Strategies to Target Tumor Immunosuppression

  2020cites this paper
• Toll-like Receptors from the Perspective of Cancer Treatment

  2020cites this paper
• Metastatic Colonization: Escaping Immune Surveillance

  2020cites this paper
• Type 1 conventional dendritic cells are systemically dysregulated early in pancreatic carcinogenesis

  2020cites this paper
• Multidirectional Strategies for Targeted Delivery of Oncolytic Viruses by Tumor Infiltrating Immune Cells.

  2020cites this paper
• Systemic dysfunction and plasticity of the immune macroenvironment in cancer models

  2020cites this paper
• Therapeutic Efficacy of Delta-Like Ligand 4 Gene Vaccine Overexpression on Liver Cancer in Mice

  2020cites this paper
• The abscopal effect 67 years later: from a side story to center stage.

  2020cites this paper
• Dendritic Cells and Immunogenic Cancer Cell Death: A Combination for Improving Antitumor Immunity

  2020cites this paper
• The Development, Function, and Plasticity of the Immune Macroenvironment in Cancer

  2019cites this paper
• Inmuno-monitoreo del componente de células presentadoras de antígeno (APC) y células T en distintos estadios del desarrollo de cáncer gástrico de tipo intestinal

  2019cites this paper
• Circulating Plasmacytoid and Myeloid Dendritic Cells in Breast Cancer Patients: A Pilot Study

  2019cites this paper
• The Contribution of the Immune System in Bone Metastasis Pathogenesis

  2019cites this paper
• IL-15 and a Two-Step Maturation Process Improve Bone Marrow-Derived Dendritic Cell Cancer Vaccine

  2019cites this paper
• Interplay between dendritic cells and cancer cells.

  2019cites this paper
• Notch Signaling in Myeloid Cells as a Regulator of Tumor Immune Responses

  2018cites this paper
• Cancer RNome: Evolution and Sustenance

  2018cites this paper
• Targeting NOX2 in cancer

  2018cites this paper
• Does the Immunocompetent Status of Cancer Patients Have an Impact on Therapeutic DC Vaccination Strategies?

  2018cites this paper
• IRX-2 natural cytokine biologic for immunotherapy in patients with head and neck cancers

  2018cites this paper
• Redox reactions in cancer: impact and regulation

  2018cites this paper
• [Immune system and tumors].

  2017cites this paper
• Adaptive immunity programmes in breast cancer

  2017cites this paper
• Monocyte-derived dendritic cells from patients with cervical intraepithelial lesions.

  2017cites this paper
• Immunomodulatory Activity of VEGF in Cancer.

  2017cites this paper
• The risk of breast cancer relapse depends both on tumor extent and biological Main immunoregulatory mechanisms that favor breast cancer development

  2017cites this paper
• Système immunitaire et tumeurs

  2017cites this paper
• [Main immunoregulatory mechanisms that favor breast cancer development].

  2017cites this paper
• Myeloid cells in circulation and tumor microenvironment of breast cancer patients

  2017cites this paper
• Melanomas and Dysplastic Nevi Differ in Epidermal CD1c+ Dendritic Cell Count

  2017cites this paper
• Dendritic Cells Inhibited by Tumor-Derived Antigen-Processing Machinery in Human Restoration by IL-15 of MHC Class I

  2017cites this paper
• Regulation of Natural Killer Cell Function by STAT3

  2016cites this paper
• Adaptive immunity programs in breast cancer Adaptive immunity in breast cancer

  2016cites this paper
• The predictive value of dendritic cells in early squamous cell carcinoma of the tongue.

  2016cites this paper
• Rôles de deux corécepteurs impliqués dans le maintien des cellules T mémoires CD8+ et la maturation des cellules dendritiques

  2016cites this paper
• Differential Effects of Viscum album Preparations on the Maturation and Activation of Human Dendritic Cells and CD4+ T Cell Responses

  2016cites this paper
• COX-2 Dependent Modulation of Immune Activity in Lung Cancer

  2016cites this paper
• Dendritic Cell Vaccines.

  2016cites this paper
• On the origin of myeloid-derived suppressor cells

  2016cites this paper
• Understanding Tumor-Antigen Presentation in the New Era of Cancer Immunotherapy.

  2016cites this paper
• Characterization of dendritic cells in lip and oral cavity squamous cell carcinoma.

  2016cites this paper
• Immune modulation by ER stress and inflammation in the tumor microenvironment.

  2016cites this paper
• Human mesothelioma induces defects in dendritic cell numbers and antigen-processing function which predict survival outcomes

  2016cites this paper
• Cellular immune responses towards regulatory cells.

  2016cites this paper
• Immunotherapeutic Modalities in the Treatment of Head & Neck Squamous Cell Carcinoma

  2016cites this paper
• Biophysical Characteristics of DCs in Tumor Microenvironment

  2015cites this paper
• O microambiente supressor no câncer: efeitos locais e sistêmicos em monócitos de pacientes.

  2015cites this paper
• MUC1 as a Potential Target in Anticancer Therapies

  2015cites this paper
• Enhancement of the Immunostimulatory Functions of Ex Vivo–Generated Dendritic Cells from Early-Stage Colon Cancer Patients by Consecutive Exposure to Low Doses of Sequential-Kinetic-Activated IL-4 and IL-12. A Preliminary Study

  2015cites this paper
• Monocyte-derived dendritic cells reflect the immune functional status of a chromophobe renal cell carcinoma patient: Could it be a general phenomenon?

  2015cites this paper
• Stress Response Pathways in Cancer

  2015cites this paper
• Development of a potent melanoma vaccine capable of stimulating CD8+ T-cells independently of dendritic cells in a mouse model

  2015cites this paper
• Lipid-based nanoparticles for altering immune response: A step towards targeted cancer immunotherapy

  2015cites this paper
• ResearchAlterations of dendritic cell subsets in the peripheral circulation of patients with cervical carcinoma

  2015cites this paper
• Combined immunotherapy with whole tumor lysate-pulsed interleukin-15-activated dendritic cells and cucurbitacin I promotes strong CD8(+) T-cell responses and cures highly aggressive lymphoma.

  2015cites this paper
• Cell-Nonautonomous ER Stress-Mediated Dysregulation of Immunity by Cancer Cells

  2015cites this paper
• The Role of Chemokine Receptors CCR6 and CCR7 in the Initiation and Progression of Breast Cancer

  2015cites this paper
• The chemokine receptor CCR6 facilitates the onset of mammary neoplasia in the MMTV-PyMT mouse model via recruitment of tumor-promoting macrophages

  2015cites this paper
• The Importance of Lamivudine Therapy in Liver Cirrhosis Patients Related HBV with Advanced Hepatocellular Carcinoma Receiving Hepatic Arterial Infusion Chemotherapy

  2015cites this paper
• Cancer vaccines

  2015cites this paper
• Extending the lifespan and efficacies of immune cells used in adoptive transfer for cancer immunotherapies–A review

  2015cites this paper
• Inhibition of vascular endothelial growth factor by small interfering RNA upregulates differentiation, maturation and function of dendritic cells

  2014cites this paper
• Immune regulation of bone metastasis.

  2014cites this paper
• Liver metastases induce reversible hepatic B cell dysfunction mediated by Gr‐1+CD11b+ myeloid cells

  2014cites this paper
• Enhancement of Antitumor Immunity Using a DNA-Based Replicon Vaccine Derived from Semliki Forest Virus

  2014cites this paper
• Artificial antigen-presenting cells expressing CD80, CD70, and 4-1BB ligand efficiently expand functional T cells specific to tumor-associated antigens.

  2014cites this paper
• Antigen trapping by dendritic cells for antitumor therapy.

  2014cites this paper
• Myeloid derived suppressor and dendritic cell subsets are related to clinical outcome in prostate cancer patients treated with prostate GVAX and ipilimumab

  2014cites this paper
• Angiogenesis and Immune Suppression in Cancer

  2014cites this paper
• CD1d levels in peripheral blood of patients with acute myeloid leukemia and acute lymphoblastic leukemia

  2014influential citation
• Host Immunity Influences the Efficacy of Combined Intra-Arterial Chemotherapy for Advanced Hepatocellular Carcinoma in Liver Cirrhosis Patients.

  2014cites this paper
• Tumor-induced perturbations of cytokines and immune cell networks.

  2014cites this paper
• Low expression of dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin in non-Hodgkin lymphoma and a significant correlation with β2-microglobulin

  2014cites this paper
• A decision support system for the re-equilibrium of PPP contracts

  2014cites this paper
• Nonneuronal Cholinergic System in Breast Tumors and Dendritic Cells: Does It Improve or Worsen the Response to Tumor?

  2013cites this paper
• Cell Apoptosis Ceramide Mediates Tumor-Induced Dendritic

  2013cites this paper
• Defective Generation and Maturation of Dendritic Cells from Monocytes in Colorectal Cancer Patients during the Course of Disease

  2013cites this paper
• Dendritic Cells Pulsed with Viral Oncolysate

  2013cites this paper
• Dendritic Cell-Based Cancer Immunotherapy: Achievements and Novel Concepts

  2013cites this paper
• IRX-2, a Novel Immunotherapeutic, Enhances Functions of Human Dendritic Cells

  2013cites this paper
• Breast Cancer Stem Cells, Pathways and Therapeutic Perspectives 2011

  2013cites this paper
• Influence of etiology on host immunity in liver cirrhosis patients with advanced hepatocellular carcinoma receiving intra-arterial chemotherapy.

  2013cites this paper
• The Role of Inflammation and Autoimmunity in the Pathophysiology of Pulmonary Arterial Hypertension

  2013cites this paper
• Dendritic cells in Barrett's esophagus carcinogenesis: an inadequate microenvironment for antitumor immunity?

  2013cites this paper
• Inhibitory effects of neural stem cells derived from human embryonic stem cells on differentiation and function of monocyte-derived dendritic cells.

  2013cites this paper
• Changes in peripheral blood immune cells: their prognostic significance in metastatic renal cell carcinoma patients treated with molecular targeted therapy

  2013cites this paper